Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CCR1 | P32246 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SPR | P35270 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1775261 | 0.89 | POLB (0.46) | GAACCR1KDM4EPOLBTSHR | |
| SCHEMBL1774525 | 0.87 | GAA (0.43) | GAACCR1KDM4EPOLBTSHR | |
| SCHEMBL1774312 | 0.87 | GAA (0.41) | GAACCR1KDM4EPOLBTSHR | |
| SCHEMBL13523714 | 0.85 | GAA (0.50) | GAACCR1KDM4EPOLBTSHR | |
| SCHEMBL1045128 | 0.83 | GAA (0.42) | GAACCR1KDM4EPOLBTSHR | |
| SCHEMBL13169907 | 0.82 | GAA (0.46) | GAACCR1KDM4EPOLBTSHR | |
| SCHEMBL2595414 | 0.81 | CCR1 (0.41) | GAACCR1KDM4EPOLBTSHR | |
| SCHEMBL2599385 | 0.81 | GAA (0.46) | GAACCR1KDM4EPOLBTSHR | |
| SCHEMBL20801744 | 0.81 | GAA (0.51) | GAACCR1KDM4EPOLBTSHR | |
| SCHEMBL1228464 | 0.81 | GAA (0.51) | GAACCR1KDM4EPOLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100286147-A1 | FUNGICIDAL AMIDES | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2010-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100286147-A1 | FUNGICIDAL AMIDES | NAT1, NOX1, CBR1 | GAA 358/4885CCR1 655/4885KDM4E 904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.